Genor Biopharma Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
538.00
523.00
-748.00
-851.00
-1,044.00
-3,411.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-402.00
-9.00
-6.00
90.00
34.00
-242.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
286.00
716.00
-469.00
-675.00
-752.00
-881.00
Cash Flow from Investing Activities
910.00
-216.00
6.00
-15.00
-65.00
-110.00
Cash Flow from Financing Activities
-598.00
-462.00
-7.00
-65.00
22.00
4,200.00
Net Cash Inflow / Outflow
594.00
43.00
-467.00
-713.00
-878.00
3,009.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
5.00
3.00
41.00
-82.00
-199.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Genor Biopharma Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
538.212075095034
-640.368622755332
1,178.00
184.05%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-402.493735959434
-32.3250496404269
-370.00
-1145.14%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
286.673147106483
-372.52630159841
658.00
176.95%
Cash Flow from Investing Activities
910.890094546562
-16.7241527706307
926.00
5546.55%
Cash Flow from Financing Activities
-598.472531665866
109.110866390433
-707.00
-648.50%
Net Cash Inflow / Outflow
594.194086968366
-269.466488472994
863.00
320.51%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.89662301881265
10.6730995056135
-14.00
-145.88%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -60.01% vs 252.59% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
286.67
716.81
-60.01%






